Are we ready to change treatment planning for left-side breast cancer radiotherapy?
نویسندگان
چکیده
منابع مشابه
Chemoprevention for breast cancer: are we ready?
Despite recent advances in the management of breast cancer, there has been no noticeable improvement in the mortality rate. In fact, the reported incidence of breast cancer is rising (7,2). Although early detection through mammography screening may contribute to this increase, the main causes have yet to be delineated (3). Factors that concern many investigators include changes in dietary habit...
متن کاملVitamin D: Are We Ready to Supplement for Breast Cancer Prevention and Treatment?
Vitamin D deficiency is a potentially modifiable risk factor that may be targeted for breast cancer prevention and treatment. Preclinical studies support various antitumor effects of vitamin D in breast cancer. Numerous observational studies have reported an inverse association between vitamin D status, including circulating 25-hydroxyvitamin D (25(OH)D) levels, and breast cancer risk. The rela...
متن کاملAre we ready for conservative treatment in ovarian cancer?
To the editor: Ovarian cancer is a rare malignancy, which is the 4th in frequency of all gynecologic malignancies; however, it represents the most lethal gynecological cancer. Ovarian cancer in young patients is also rare; it is considered that 3% to 17% of all epithelial ovarian cancers occur in women less than 40 years. The presentation of majority epithelial ovarian cancers is in advanced st...
متن کاملGlobal Health Governance Challenges 2016 – Are We Ready?
The year 2016 could turn out to be a turning point for global health, new political realities and global insecurities will test governance and financing mechanisms in relation to both people and planet. But most importantly political factors such as the global power shift and “the rise of the rest” will define the future of global health. A new mix of health inequity and security challenges has...
متن کاملAre we ready to start outpatient treatment for pulmonary embolism?
Thromb Haemost 2008; 100: 736–737 Ten years ago, most patients suffering from pulmonary embolism (PE) were given intravenous heparin and were confined to bed for several days, even if the disease was clinically stable. The advent of subcutaneous treatment with low-molecular-weight heparins (LMWH) and less intensive monitoring made it possible for patients to become mobile again much sooner, wit...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nowotwory
سال: 2022
ISSN: ['0029-540X', '2300-2115']
DOI: https://doi.org/10.5603/njo.2022.0038